Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Meeting on the Med 2021 | Manufacturing advanced therapies for AMD

Jane Lebkowski, PhD, Regenerative Patch Technologies, Portola Valley, CA, explores the challenges in manufacturing cell and gene therapies for age related macular degeneration (AMD) and other indications. Given the large number of patients with AMD, it is important for developers to scale manufacturing in order to meet the high demand for therapies while reducing costs. Dr. Lebkowski discusses the benefits of investing in manufacturing at an early stage in the development process, the implementation of automated manufacturing technologies and the importance of appropriate potency assays and cellular characterization. This interview took place during the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.